IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA. (2025). Frontier in Medical and Health Research, 3(10), 570-577. https://fmhr.net/index.php/fmhr/article/view/1765